• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biomed Res Int . Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retr

tetano

Editor, Senior Moderator
Biomed Res Int


. 2020 Nov 6;2020:9126148.
doi: 10.1155/2020/9126148. eCollection 2020.
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital


Eleftheria Kampouri[SUP] 1 [/SUP], Paraskevas Filippidis[SUP] 1 [/SUP], Benjamin Viala[SUP] 1 [/SUP], Marie M?an[SUP] 2 [/SUP], Olivier Pantet[SUP] 3 [/SUP], Florian Desgranges[SUP] 1 [/SUP], Jonathan Tschopp[SUP] 1 [/SUP], Jean Regina[SUP] 1 [/SUP], Eleftherios Karachalias[SUP] 4 [/SUP], Christophe Bianchi[SUP] 2 [/SUP], Maxime G Zermatten[SUP] 5 [/SUP], Katia Jaton[SUP] 6 [/SUP], Salah Dine Qanadli[SUP] 7 [/SUP], Pierre-Alexandre Bart[SUP] 2 [/SUP], Jean-Luc Pagani[SUP] 3 [/SUP], Benoit Guery[SUP] 1 [/SUP], Lorenzo Alberio[SUP] 5 [/SUP], Matthaios Papadimitriou-Olivgeris[SUP] 1 8 [/SUP], RegCOVID Research Group[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) can result in profound changes in blood coagulation. The aim of the study was to determine the incidence and predictors of venous thromboembolic events (VTE) among patients with COVID-19 requiring hospital admission. Subjects and Methods. We performed a retrospective study at the Lausanne University Hospital with patients admitted because of COVID-19 from February 28 to April 30, 2020.
Results: Among 443 patients with COVID-19, VTE was diagnosed in 41 patients (9.3%; 27 pulmonary embolisms, 12 deep vein thrombosis, one pulmonary embolism and deep vein thrombosis, one portal vein thrombosis). VTE was diagnosed already upon admission in 14 (34.1%) patients and 27 (65.9%) during hospital stay (18 in ICU and nine in wards outside the ICU). Multivariate analysis revealed D-dimer value > 3,120 ng/ml (P < 0.001; OR 15.8, 95% CI 4.7-52.9) and duration of 8 days or more from COVID-19 symptoms onset to presentation (P 0.020; OR 4.8, 95% CI 1.3-18.3) to be independently associated with VTE upon admission. D-dimer value ≥ 3,000 ng/l combined with a Wells score for PE ≥ 2 was highly specific (sensitivity 57.1%, specificity 91.6%) in detecting VTE upon admission. Development of VTE during hospitalization was independently associated with D-dimer value > 5,611 ng/ml (P < 0.001; OR 6.3, 95% CI 2.4-16.2) and mechanical ventilation (P < 0.001; OR 5.9, 95% CI 2.3-15.1).
Conclusions: VTE seems to be a common COVID-19 complication upon admission and during hospitalization, especially in ICU. The combination of Wells ≥ 2 score and D - dimer ≥ 3,000 ng/l is a good predictor of VTE at admission.
 
Back
Top Bottom